Concepedia

Publication | Open Access

Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024

DOIFull Paper Access

41

Citations

25

References

2024

Year

Heidi L. Moline, Ariana P. Toepfer, Ayzsa Tannis, Geoffrey A. Weinberg, Mary Allen Staat, Natasha Halasa, Julie A. Boom, Eileen J. Klein, John V. Williams, Jennifer E. Schuster,
JAMA Pediatrics

Abstract

This analysis documented the continued high burden of medically attended RSV-associated ARI among young children in the US. There is a potential for substantial public health impact with increased and equitable prevention product coverage in future seasons.

References

YearCitations

Page 1